1. Home
  2. VATE vs LNSR Comparison

VATE vs LNSR Comparison

Compare VATE & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$11.94

Market Cap

168.2M

Sector

Industrials

ML Signal

HOLD

Logo LENSAR Inc.

LNSR

LENSAR Inc.

SELL

Current Price

$5.66

Market Cap

146.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VATE
LNSR
Founded
1994
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical Electronics
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
168.2M
146.7M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
VATE
LNSR
Price
$11.94
$5.66
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
51.2K
67.2K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,246,000,000.00
$58,435,000.00
Revenue This Year
N/A
$10.06
Revenue Next Year
N/A
$41.48
P/E Ratio
N/A
N/A
Revenue Growth
12.55
9.24
52 Week Low
$3.75
$5.06
52 Week High
$13.46
$13.74

Technical Indicators

Market Signals
Indicator
VATE
LNSR
Relative Strength Index (RSI) 60.40 45.77
Support Level $4.47 $5.25
Resistance Level $13.34 $6.39
Average True Range (ATR) 1.05 0.33
MACD -0.17 0.15
Stochastic Oscillator 42.52 68.67

Price Performance

Historical Comparison
VATE
LNSR

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.

Share on Social Networks: